9 results
PRE 14A
THRX
Theseus Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
9:00am
or Native American
Asian
Hispanic or Latino
Native Hawaiian or Pacific Islander
White
Two or More Races or Ethnicities
LGBTQ+
Did Not Disclose Demographic
DEF 14A
THRX
Theseus Pharmaceuticals Inc
25 Apr 22
Definitive proxy
4:30pm
Part I: Gender Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latino
10-K
2021 FY
THRX
Theseus Pharmaceuticals Inc
10 Mar 22
Annual report
7:23am
the EGFR kinase domain were found in approximately 10% to 15% of caucasian NSCLC patients and up to 50% of East-Asian NSCLC patients
424B4
THRX
Theseus Pharmaceuticals Inc
7 Oct 21
Prospectus supplement with pricing info
5:03pm
% to 15% of caucasian NSCLC patients and up to 50% of East-Asian NSCLC patients, and it was in these patients where strong response to first-generation
S-1/A
vm24192
30 Sep 21
IPO registration (amended)
6:33am
S-1
c0jieqv6d8gcfmpj
15 Sep 21
IPO registration
4:04pm
DRS/A
7t63bz
23 Aug 21
Draft registration statement (amended)
12:00am
DRS
gmhirqgbq 12nlh
20 Jul 21
Draft registration statement
12:00am
- Prev
- 1
- Next